Zobrazeno 1 - 10
of 23
pro vyhledávání: '"S. Nissel-Horowitz"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bhoomi Mehrotra, Neetu Radhakrishnan, Matthew Kaufman, G. Gecelter, S. Nissel-Horowitz, James Tsang, R. Roy, A. Thomas
Publikováno v:
Colorectal Disease. 10:498-502
Background The role of palliative surgical resection in patients presenting with locally advanced or metastatic colorectal cancer (CRC) is unclear. Resection is often limited to symptomatic management of bleeding, obstruction, perforation or for reli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96b5d38dd0c0127e8965016bea5c8f80
https://doi.org/10.1111/j.1463-1318.2007.01384.x
https://doi.org/10.1111/j.1463-1318.2007.01384.x
Autor:
Rajasree Roy, S. Nissel-Horowitz, Dilip Patel, Bhoomi Mehrotra, Angela Caramalis, A. Thomas, Lawrence H Durban, Melanie Diaz, Wallace Chan
Publikováno v:
Journal of Clinical Oncology. 35:e20509-e20509
e20509 Background: Immunotherapy (IT) response measurements in advanced NSCLC management are evolving. We describe here our retrospective single institutional experience in measuring serum CEA levels as an early response determinant and correlation w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::806c3e8e549ef8c3161baa6fc517a9e9
https://doi.org/10.1200/jco.2017.35.15_suppl.e20509
https://doi.org/10.1200/jco.2017.35.15_suppl.e20509
Autor:
Sewanti Limaye, Yehuda Lebowicz, Bhoomi Mehrotra, Alexander Fuchs, Sherrie White, S. Nissel-Horowitz, A. Thomas, Matthew Kaufman
Publikováno v:
International Journal of Medical Sciences
BACKGROUND: Increased epidermal growth factor receptor (EGF receptor) expression has been noted in various cancers and has become a useful target for therapeutic interventions. Small studies from Asia and Australia have demonstrated EGFR over-express
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0adcfd9a8387043956fa291495721cc9
https://pubmed.ncbi.nlm.nih.gov/18825277
https://pubmed.ncbi.nlm.nih.gov/18825277
Publikováno v:
American journal of clinical oncology. 25(1)
Gemcitabine is a pyrimidine analog with a similar chemical structure and mechanism of action, as cytarabine. It has been shown to be a highly active agent for non-small cell lung cancer, pancreatic cancer, urothelial cancer, breast cancer and ovarian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aff268accd2cec809b3ce033f007afa1
https://pubmed.ncbi.nlm.nih.gov/11823707
https://pubmed.ncbi.nlm.nih.gov/11823707
Publikováno v:
American journal of hematology. 66(2)
Intravenous gammaglobulins are used for the treatment of various auto-immune hematological disorders. Renal failure is a relatively rare, but an increasingly recognized side effect of gammaglobulin therapy. Although the renal failure is usually rever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::254da17a7a2cf5e7dc6e11cabbc61e82
https://pubmed.ncbi.nlm.nih.gov/11421298
https://pubmed.ncbi.nlm.nih.gov/11421298
Publikováno v:
Journal of Clinical Oncology. 29:e14624-e14624
e14624 Background: Carcinoid tumors are known to secrete neurohumoral substances resulting in the manifestation of carcinoid syndrome. There are only rare reports of severe psychiatric symptoms associated with carcinoid disease. We report our institu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fd6927d77ac53a5980b6d57c38773d5
https://doi.org/10.1200/jco.2011.29.15_suppl.e14624
https://doi.org/10.1200/jco.2011.29.15_suppl.e14624
Publikováno v:
American Journal of Hematology. 66:151-152
Intravenous gammaglobulins are used for the treatment of various auto-immune hematological disorders. Renal failure is a relatively rare, but an increasingly recognized side effect of gammaglobulin therapy. Although the renal failure is usually rever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d7078c77ee90a7e9990db06e1bd4ca7
https://doi.org/10.1002/1096-8652(200102)66:2<151::aid-ajh1035>3.0.co
https://doi.org/10.1002/1096-8652(200102)66:2<151::aid-ajh1035>3.0.co
Publikováno v:
Journal of Clinical Oncology. 26:17033-17033
17033 Background: Concomitant chemoradiotherapy (CRT) with cisplatin, given every three weeks, is a standard treatment option in the management of unresectable/ locally advanced squamous cell carci...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4402326e60a72007504c6b7e1a9c7229
https://doi.org/10.1200/jco.2008.26.15_suppl.17033
https://doi.org/10.1200/jco.2008.26.15_suppl.17033
Publikováno v:
Journal of Clinical Oncology. 26:6043-6043
6043 Background: Management of nodal neck disease in patients with SCHNC (squamous cell carcinoma of the head and neck) treated with CRT (chemoradiotherapy) remains controversial. We retrospectively evaluated the utility of PET scans in monitoring re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52d382750bd82b4f6a7801f1e36f72a8
https://doi.org/10.1200/jco.2008.26.15_suppl.6043
https://doi.org/10.1200/jco.2008.26.15_suppl.6043